FDA Warns Website Operators Illegally Selling Opioids to Consumers

The U.S. Food and Drug Administration has issued warning letters to 17 website operators for illegally selling unapproved and misbranded opioids online in violation of the Federal Food, Drug, and Cosmetic Act. Misbranded opioids include those offered for sale without a prescription, as well as opioids that lack adequate directions for use. The opioids offered Read More

Rural Development Expert Takes Aim at Rural Drug Addiction

Anne Hazlett, formerly assistant to the secretary for Rural Development at the U.S. Department of Agriculture, has pivoted to address a specific ill plaguing rural counties, serving now as the senior adviser at the White House Office of National Drug Control Policy (ONDCP). She’s leading the agency’s multi-faceted approach toward illicit drugs — addiction prevention, Read More

For Those Who Are Serious About Increasing Access to MAT for Opioid Use Disorder…

By Jeffrey A. Singer The synthetic opioid methadone, developed in Germany in the 1930s for the treatment of severe pain, has been employed for the Medication Assisted Treatment (MAT) of heroin addiction and opioid use disorder since the 1960s. In the US, methadone clinics are tightly regulated by the Drug Enforcement Administration and the Substance Abuse Read More

Preventing opioid misuse and addiction: New thinking and the latest evidence

Drug policy often comprises efforts to reduce the supply of drugs, to provide health and social services to addicted individuals, and to prevent the development of addiction in the first place. The last of these efforts—prevention—is the subject of this paper. The scientific literature on drug policy offers some insights on the relative effectiveness and Read More